ID: ALA495022

Max Phase: Preclinical

Molecular Formula: C10H9NO2

Molecular Weight: 175.19

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1ccc2[nH]c(=O)c(O)cc2c1

Standard InChI:  InChI=1S/C10H9NO2/c1-6-2-3-8-7(4-6)5-9(12)10(13)11-8/h2-5,12H,1H3,(H,11,13)

Standard InChI Key:  HHBIREFHPDVOQC-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 175.19

Molecular Weight (Monoisotopic): 175.0633

AlogP: 1.54

#Rotatable Bonds: 0

Polar Surface Area: 53.09

Molecular Species: NEUTRAL

HBA: 2

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 3

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 6.97

CX Basic pKa:

CX LogP: 1.86

CX LogD: 1.30

Aromatic Rings: 2

Heavy Atoms: 13

QED Weighted: 0.64

Np Likeness Score: -0.43

References

1. Duplantier AJ, Becker SL, Bohanon MJ, Borzilleri KA, Chrunyk BA, Downs JT, Hu LY, El-Kattan A, James LC, Liu S, Lu J, Maklad N, Mansour MN, Mente S, Piotrowski MA, Sakya SM, Sheehan S, Steyn SJ, Strick CA, Williams VA, Zhang L..  (2009)  Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.,  52  (11): [PMID:19438227] [10.1021/jm900128w]

Source

Source(1):

• Scientific Literature